RecruitingNCT06589999

Detection of Spinal Cord Lesions Using the MP2RAGE Sequence in Inflammatory Diseases of the Neuraxis


Sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Enrollment

196 participants

Start Date

Jul 31, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Since the last revision of the MRI guidelines in multiple sclerosis (MS, MAGNIMS) and the McDonald criteria in 2017, all spinal cord lesions must be counted to increase the sensitivity and specificity of the diagnosis of MS. Focal lesions of the spinal cord are more frequently located in the cervical segments than in the lower segments of the spinal cord and occupy the lateral and posterior columns, although the central grey matter may not be spared. Cervical involvement is difficult to study because of the small size of the lesions and the loss of signal in the cervical region. As a result, the detection of cervical lesions on MRI is sub-optimal. In this context, standardised acquisition protocols have been proposed. For MRI of the spinal cord, at least two of the following sagittal sequences are recommended: T2, STIR, double inversion recovery, T1 with gadolinium injection, and/or T2 axial acquisitions. Recently, our team validated the superiority of 3D PSIR and 3D FGAPSIR sequences, which offer better detection performance than T2 and STIR on 3 Tesla MRI. Other studies have also shown the contribution of the MP2RAGE sequence to the detection of spinal cord lesions in MS, compared with the set of sequences classically recommended. The MP2RAGE sequence is a T1 sequence, which creates a composite image, limiting field inhomogeneity bias while providing a quantitative T1 map. It has recently been optimised for the spinal cord, and has been only minimally evaluated in the context of MS. The aim of this study is to evaluate the effectiveness of the MP2RAGE sequence in comparison with the set of conventional sequences recommended for the detection of spinal cord lesions in MS patients.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a specialized MRI technique called MP2RAGE, which researchers hope can better detect damage to the spinal cord in people with inflammatory neurological diseases (such as multiple sclerosis). The procedure adds minimal time to a standard MRI scan. **You may be eligible if...** - You are over 18 years old - You are already scheduled for a 1.5T or 3T MRI of the spinal cord as part of your medical care for a suspected or confirmed inflammatory neurological disease - You consent to participate and are a member of a social security scheme (France-based study) **You may NOT be eligible if...** - You are pregnant - You are under legal guardianship or a protection order - You have a reason you cannot safely undergo an MRI (e.g., certain metal implants or severe claustrophobia) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTMP2RAGE sequence

Addition of MRI sequence MP2RAGE


Locations(1)

Hopital Fondation Adolphe de Rothschild

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06589999


Related Trials